“Terminal Anorexia”, Treatment Refusal and Decision-Making Capacity
Cambridge Quarterly of Healthcare Ethics · 2024-10 · 33 (4) · 558-569
DOI: 10.1017/s0963180124000367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cambridge Quarterly of Healthcare Ethics, 2024-10. Verfasst von Anneli Jefferson. Beteiligte Einrichtung: School of English, Communication and Philosophy, Cardiff University, Cardiff, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Whether anorexic patients should be able to refuse treatment when this refusal potentially has a fatal outcome is a vexed topic. A recent proposal for a new category of “terminal anorexia” suggests criteria when a move to palliative care or even physician-assisted suicide might be justified. The author argues that this proposed diagnosis presents a false sense of certainty of the illness trajectory by conceptualizing anorexia in analogy with physical disorders and stressing the effects of starvation. Furthermore, this conceptualization is in conflict with the claim that individuals who meet the diagnostic criteria for terminal anorexia have decision-making capacity. It should therefore be rejected.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of English, Communication and Philosophy, Cardiff University, Cardiff, UK.
ORCID-Profile: Anneli Jefferson
Zitieren
APA
Jefferson, A. (2024). “Terminal Anorexia”, Treatment Refusal and Decision-Making Capacity. Cambridge Quarterly of Healthcare Ethics. https://doi.org/10.1017/s0963180124000367
Vancouver
Jefferson A. “Terminal Anorexia”, Treatment Refusal and Decision-Making Capacity. Cambridge Quarterly of Healthcare Ethics. 2024. doi:10.1017/s0963180124000367
BibTeX
@article{Jefferson2024,
author = {Jefferson, Anneli},
title = {“Terminal Anorexia”, Treatment Refusal and Decision-Making Capacity},
journal = {Cambridge Quarterly of Healthcare Ethics},
year = {2024},
doi = {10.1017/s0963180124000367}
}
EUVIMED